Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.4K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

922
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
922
Gene Therapy00:59

Gene Therapy

26.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

652
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
652

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Real-World Outcomes of OnabotulinumtoxinA and CGRP Monoclonal Antibodies in Chronic Migraine.

Journal of clinical medicine·2026
Same author

Stereotactic radiosurgery for post-herpetic trigeminal neuralgia: results of a case-control study.

BMC neurology·2026
Same author

TiO<sub>2</sub> Nanoparticles Trigger Gut-to-Gill Bacterial Translocation and Dysbiosis in Zebrafish.

International journal of molecular sciences·2026
Same author

Boron neutron capture therapy plus bevacizumab versus bevacizumab alone in recurrent glioblastoma: A propensity score-matched analysis.

Neuro-oncology advances·2026
Same author

Tumor necrosis factor-alpha-mediated inflammatory bone loss: Pathogenic mechanisms and therapeutic potential of its inhibitors.

Tzu chi medical journal·2026
Same author

White matter microdissection of the medial aspect of the brain: 2-dimensional video demonstration.

Acta neurochirurgica·2026

Related Experiment Video

Updated: Nov 29, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.0K

Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies.

Wen-Ying Lin1, Hsin-Hui Wang2,3,4, Yi-Wei Chen5,6

  • 1Department of Internal Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan.

International Journal of Molecular Sciences
|November 20, 2020
PubMed
Summary

Chimeric antigen receptor (CAR) T-cell therapy shows promise for blood cancers but faces clinical challenges. Ongoing research aims to expand its use and improve efficacy in treating hematological malignancies.

Keywords:
acute lymphoblastic leukemia (ALL)chimeric antigen receptor (CAR)-T cellsdiffuse large B cell lymphoma (DLBCL)gene modified-based cellular platformimmunotherapymultiple myeloma (MM)

More Related Videos

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

18.8K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.6K

Related Experiment Videos

Last Updated: Nov 29, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.0K
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

18.8K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.6K

Area of Science:

  • Immunology
  • Oncology
  • Cellular Therapy

Background:

  • Advances in molecular understanding have identified specific antigens on hematological malignant cells.
  • Targeted therapies, including CAR T-cell therapy, have been developed to treat these cancers.

Purpose of the Study:

  • To review the current status of CAR T-cell therapy in hematological malignancies.
  • To discuss molecular aspects, clinical applications, adverse reactions, challenges, and future directions.

Main Methods:

  • Review of current literature and clinical trial data on CAR T-cell therapy.
  • Analysis of molecular targets, therapeutic efficacy, and safety profiles.

Main Results:

  • CAR T-cell therapy has gained FDA approval for specific relapsed/refractory lymphomas and leukemias.
  • Significant clinical challenges remain regarding broader applicability, efficacy, and persistence.

Conclusions:

  • CAR T-cell therapy is a rapidly evolving immunotherapy with transformative potential in hematological malignancies.
  • Further research and clinical trials are crucial to overcome existing challenges and optimize patient outcomes.